Lifshitz & Miller Law Firm Announces Investigation of Auxilium Pharmaceuticals Inc., First Citizens Bancorporation, Medical Action Industries Inc., Regado Biosciences, Inc., Sport Chalet Inc., and Vitacost.com, Inc.

NEW YORK, July 4, 2014 /PRNewswire/ --

Auxilium Pharmaceuticals Inc.

Lifshitz & Miller announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Auxilium Pharmaceuticals Inc. ("AUXL") to Owens & Minor, Inc. in an all-stock deal valued at approximately $851 million.

Lifshitz & Miller's investigation is focused on whether the AUXL directors are acting in shareholders best interest.

For information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at [phone] or by sending an e-mail including your contact information to: [e-mail].

First Citizens Bancorporation

Lifshitz & Miller announces an investigation into possible breaches of fiduciary duty in connection with the proposed merger of First Citizens Bancorporation ("FCBN") to First Citizens BancShares, Inc. ("FCNCA") in a transaction valued between $636.9 million and $676.4 million.

For information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at [phone] or by sending an e-mail including your contact information to: [e-mail].

Medical Action Industries Inc.

Lifshitz & Miller announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Medical Action Industries Inc. ("MDCI") to Owens & Minor, Inc. in a cash transaction of $13.80 per share, or $208 million.

Lifshitz & Miller's investigation is focused on whether the MDCI directors are acting in shareholders best interest.

For information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at [phone] or by sending an e-mail including your contact information to: [e-mail].

Regado Biosciences, Inc.

Lifshitz & Miller announces that it is investigating potential claims against the board of Regado Biosciences, Inc. (RGDO). Specifically, on July 2, 2014, the company announced that the DSMB has initiated an unplanned review of data from the REGULATE-PCI trial. Patient enrollment has been paused until the DSMB has completed its analysis and communicated its recommendations.

For information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at [phone] or by sending an e-mail including your contact information to: [e-mail].

Sport Chalet Inc.

Lifshitz & Miller announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Sport Chalet Inc. ("Sport Chalet") to Vestis Retail Group, LLC in a cash transaction for all Class A (SPCHA) and Class B (SPCHB) shares of Sport Chalet for $1.20 per share.

Lifshitz & Miller's investigation is focused on whether the Sport Chalet directors are acting in shareholders best interest.

For information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at [phone] or by sending an e-mail including your contact information to: [e-mail].

Vitacost.com, Inc.

Lifshitz & Miller announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Vitacost.com, Inc. ("VITC") to The Kroger Co. in a cash transaction of $8.00 per share, or approximately $280 million.

Lifshitz & Miller's investigation is focused on whether the VITC directors are acting in shareholders best interest.

For information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at [phone] or by sending an e-mail including your contact information to: [e-mail].

ATTORNEY ADVERTISING. © 2014 Lifshitz & Miller. The law firm responsible for this advertisement is Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: [phone]. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller
Phone: [phone]
Facsimile: 516-280-7376
Email: [e-mail]

SOURCE Lifshitz & Miller Law Firm